Streetbeat News

Regulatory

EIS

ISRA

SPY

USO

The White House has stated that Iran should not respond to Israel's retaliation. If Iran does respond, the U.S. will support Israel. This geopolitical tension could impact various sectors, including energy and defense.

Portfolio Pulse from Benzinga Newsdesk

October 30, 2024 | 6:27 pm

GOOG

GOOGL

Alphabet Inc (NASDAQ:GOOG)(NASDAQ:GOOGL) is receiving positive analyst reviews following strong third-quarter results, particularly in cloud, search, and YouTube segments. Analysts have raised price targets, highlighting Alphabet's AI initiatives and cloud growth. However, concerns about AI risks and antitrust issues remain.

Portfolio Pulse from Chris Katje

October 30, 2024 | 6:25 pm

PDD

PDD shares are experiencing a decline due to reports that the European Union will investigate Temu.

Portfolio Pulse from Benzinga Newsdesk

October 30, 2024 | 6:02 pm

LI

NIO

XPEV

Chinese EV stocks are declining as China instructs its automakers to stop investing in EU countries that support tariffs on Chinese-built EVs.

Portfolio Pulse from Benzinga Newsdesk

October 30, 2024 | 5:59 pm

BABA

BIDU

JD

LI

NIO

XPEV

China is considering a significant fiscal initiative to boost its economy, potentially approving over 10 trillion yuan in additional debt issuance. This includes 6 trillion yuan in special sovereign bonds to ease local government debt burdens. US-listed Chinese stocks like Alibaba, JD.com, Baidu, NIO, Li Auto, and XPeng are trading lower amid these developments.

Portfolio Pulse from Anusuya Lahiri

October 30, 2024 | 5:02 pm

TSM

Taiwan Semiconductor Manufacturing Company (TSMC) has halted chip shipments to two developers over potential links to Huawei, raising compliance concerns. Bitmain, a major bitcoin mining hardware manufacturer, faces supply disruptions due to suspicions of breaching U.S. sanctions. TSMC's stock fell 4.3% following criticism from Donald Trump, who accused Taiwan of weakening the U.S. chip industry.

Portfolio Pulse from Anusuya Lahiri

October 30, 2024 | 4:42 pm

THAR

Tharimmune, Inc. (NASDAQ:THAR) shares surged over 100% after receiving positive feedback from the European Medicines Agency (EMA) on its TH104 clinical program for treating pruritus in primary biliary cholangitis. The EMA approved the design of the Phase 2 study and provided guidance for Phase 3. Tharimmune plans to start a Phase 2 trial soon, with results expected in 2025.

Portfolio Pulse from Dylan Berman

October 30, 2024 | 4:31 pm

TGL

Treasure Global has amended its partnership agreement with Credilab, changing the profit-sharing ratio from 1/3 to 1/2. This amendment has been filed with the SEC as a supplement to the original 8-K filing.

Portfolio Pulse from Benzinga Newsdesk

October 30, 2024 | 4:19 pm